Carter-Wallace rejects $835 mil. buy-out offer; Trojan raiders?.
This article was originally published in The Tan Sheet
Executive Summary
TROJAN WARS?: CARTER-WALLACE REJECTS $18/SHARE BID BY MARVIN DAVIS on Nov. 1. The Princeton, N.J.-based consumer products and pharmaceuticals company reported Oct. 30 that it received a letter from Davis stating that his Los Angeles-based investment firm Davis Companies is "prepared to negotiate an agreement with [Carter-Wallace] for the acquisition of all of the company's outstanding stock at a price of $18 per share."